Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison Between Low Mixed Insulin and Mid Mixed Insulin AS Starter Insulin For Patients With TYpe 2 Diabetes Mellitus (CLASSIFY Study)

NCT01773473 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT01773473
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01773473 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison Between Low Mixed Insulin and Mid Mixed Insulin AS Starter Insulin For Patients With TYpe 2 Diabetes Mellitus (CLASSIFY Study)
Lead sponsor
Eli Lilly and Company
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2013
Completion date
August 31, 2014
Enrollment
403 (actual)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes mellitus